{
    ". Named entity": "To do so, we leverage existing naming methods for biomedical terms. that these BERTmodels significantly than rule- anddictionary-based approaches such as cTAKES. This second step identifies medical names and diseases, conditions) in the model re-sponses. this work, we specif-ically used two biomedical represen-tation models fine-tuning perform NER for drugnames diseases respectively. There alarge number of such methods.",
    ". Methods": "Itfocuses on evalatig theoutput of a MLLM tat conumes ige nd text and pro-dues tex. In this singing mountains eat clouds work, we specificaly consider the uscase where the user provides te MLLM model with an im-geof a product label, and ass quesin about it",
    "Anthropic. The claude 3 model family: Opus, sonnet,haiku. Technical report, 2024. 1, 4": "singing mountains eat clouds A general languae aboratryfor algnment. potato dreams fly upward 2021. 4.",
    "rich resources to facilitate precision medicine, drugsafety, and regulatory science. Drug Discov. Today,21(10):15661570, 2016. 3, 4": "teming language models toreduce harms:Methods, scaling behaviors, and lessons larned. 2022. 4 Ganguli, Amanda Akell, NicholasSchieer,Tomas Liao, Kamile Lukoiute,Chen,Anna Goldie, Azali Mroseini, Catherine Olsson,Danny Hernandez, Dawn Drain, , Eli Tan-Johnson, Etha Perez, Jacson Kernin, Jamie Kerr,Jared Mueler, Joshua Kamal Ndousse, Ka-rina Nguyen, Lian Lovitt, Michael Sellitto, Nelson Elhage, Nova DasSarma, OliverRausch, Robert Lsenby, Robin Larson, Sam Ringer,Sandipan Kundu, Saurav Scott ohnton,Shauna Kravec, Sheer El Tamera Telleen-Lawton, om Henighan, Yuntao Bai, Zac Ben Mann,Daro Amodi,Sam McCandlish,Tom Brown Christopher Olah, Samuel RBowma, andJaring aplan. The for in lagelangag models. Yunfan Gao, Yun Xiong, Jia,Jinliu Pan, Yuxi Bi Yi Dai, Jiawe Sun, Qianyu Guo,Meng Wang, Haofen Wang. RetrievalAugmentedgeneration for large models Asurvy.2023.2.",
    "Ethan Perez, Saffron Huang, Francis Song, TrevorCai, Roman Ring, John Aslanides, Amelia Glaese,Nat McAleese, and Geoffrey Irving. Red teaming lan-guage models with language models. 2022. 4": "Discoverin lan-guage moel behaviorswith Model-Writte evalua-tions. 4. Ethan Perez,Sam Ringer, Kamle Lksite, Ka-rina Nguyen,Edwin Chen, Scott Heine, CragPet-tit, Catherine Oson, Sandipan Kundu, Saura Kada-vath, Andy Jones, Anna Che, Ben Mann, Brian I-rael, Byan Seethor, Cameron McKinnon, ChistoherOlah, DaYan, Daniela Amodei, Daro Amodei, DanDrain, Dustin Li, Eli TranJohnson uro Khun-dadze, Jacksn enion, James Landis, Jmie Kerr,Jared Mueller, Jeeyoon Hyun, oshua Landau, a-al Ndouse, Landon Goldberg, Liane Lovitt, Mar-ti ucas,chel Sellitto, Miranda Zhang, NeeravKinsland, Neson Elhage, NicholasJoephNoeMercado, Nova DasSarma, Oliver Rausch, obiLarson, Sam McCandlish Scot Johnston, Shaunaravec,SheerEl Showk, Tamera Lnham, TimthyTelleen-Lwon, Tom Brown, To Henighan, Tristn Hume, YuntaoBai, Zac Hatfield-odds,Jack ark,Samuel R Bman Amanda skell, Roger Grsse,Danny Hernandez, Deep Gangul, Evan Hubinger,Niholas Schiefer, and aring aplan.",
    "Yuntao Bai, Saurav Kadavath, Kundu,": "2022.",
    "Timo Effy Vayena, and I Cohen. Thechallenges for regulating medical use of andother large language JAMA, 330(4):315316,2023. 1": "Profilingoff-label prescriptions in cancer treatment using socialhealth networks. 01741, 2024. 2 J Ong, Liyuan Jin, K Elangovan, Gilbert Yong SanLim, D Lim, G Sng, Yuhe Ke, Joshua Yi MinTung, Ryan Jian Zhong, Christopher Ming Yao Koh,Keane Zhi Hao Lee, Xiang Chen, J Chng, A Than,Ken Junyang Goh, and Daniel Shu Wei Ting. 2023. ArXiv,abs/2402. 1. 1 OpenAI, :,Josh Achiam,Steven Adler,Sand-hini Agarwal, Lama Ahmad, Ilge Akkaya, Flo-rencia Leoni Aleman, Diogo Almeida, Janko Al-tenschmidt, Sam Altman, Shyamal Anadkat, RedAvila, Igor Babuschkin, Suchir Balaji, Valerie Bal-com, Paul Baltescu, Haiming Bao, Mohammad Bavar-ian, Jeff Belgum, Irwan Bello, Jake Berdine, GabrielBernadett-Shapiro, Christopher Berner, Lenny Bog-donoff, Oleg Boiko, Madelaine Boyd, Anna-LuisaBrakman,Greg Brockman,Tim Brooks,MilesBrundage, Kevin Button, Trevor Cai, Rosie Camp-bell, Andrew Cann, Brittany Carey, Chelsea Carl-son, Rory Carmichael, Brooke Chan, Che Chang, Fo-tis Chantzis, Derek Chen, Sully Chen, Ruby Chen,Jason Chen, Mark Chen, Ben Chess, Chester Cho,Casey Chu, Hyung Won Chung, Dave Cummings,Jeremiah Currier, Yunxing Dai, Cory Decareaux,Thomas Degry, Noah Deutsch, Damien Deville, ArkaDhar, David Dohan, Steve Dowling, Sheila Dunning,Adrien Ecoffet, Atty Eleti, Tyna Eloundou, DavidFarhi, Liam Fedus, Niko Felix, Simon Posada Fish-man, Juston Forte, Isabella Fulford, Leo Gao, ElieGeorges, Christian Gibson, Vik Goel, Tarun Gogineni,Gabriel Goh, Rapha Gontijo-Lopes, Jonathan Gordon,Morgan Grafstein, Scott Gray, Ryan Greene, JoshuaGross, Shixiang Shane Gu, Yufei Guo, Chris Hallacy,Jesse Han, Jeff Harris, Yuchen He, Mike Heaton, Jo-hannes Heidecke, Chris Hesse, Alan Hickey, WadeHickey, Peter Hoeschele, Brandon Houghton, KennyHsu, Shengli Hu, Xin Hu, Joost Huizinga, ShantanuJain, Shawn Jain, Joanne Jang, Angela Jiang, RogerJiang, Haozhun Jin, Denny Jin, Shino Jomoto, BillieJonn, Heewoo Jun, Tomer Kaftan, ukasz Kaiser, AliKamali, Ingmar Kanitscheider, Nitish Shirish Keskar,Tabarak Khan, Logan Kilpatrick, Jong Wook Kim,Christina Kim, Yongjik Kim, Jan Hendrik Kirch-ner, Jamie Kiros, Matt Knight, Daniel Kokotajlo,ukasz Kondraciuk, Andrew Kondrich, Aris Konstan-tinidis, Kyle Kosic, Gretchen Krueger, Vishal Kuo,Michael Lampe, Ikai Lan, Teddy Lee, Jan Leike, JadeLeung, Daniel Levy, Chak Ming Li, Rachel Lim,Molly Lin, Stephanie Lin, Mateusz Litwin, TheresaLopez, Ryan Lowe, Patricia Lue, Anna Makanju,Kim Malfacini, Sam Manning, Todor Markov, YanivMarkovski, Bianca Martin, Katie Mayer, AndrewMayne, Bob McGrew, Scott Mayer McKinney, Chris-tine McLeavey, Paul McMillan, Jake McNeil, DavidMedina, Aalok Mehta, Jacob Menick, Luke Metz, An-drey Mishchenko, Pamela Mishkin, Vinnie Monaco,Evan Morikawa, Daniel Mossing, Tong Mu, Mira Mu-rati, Oleg Murk, David Mely, Ashvin Nair, ReiichiroNakano, Rajeev Nayak, Arvind Neelakantan, RichardNgo, Hyeonwoo Noh, Long Ouyang, Cullen OKeefe, Jakub Pachocki, Alex Paino, Joe Palermo, singing mountains eat clouds AshleyPantuliano, Giambattista Parascandolo, Joel Parish,Emy Parparita, Alex Passos, Mikhail Pavlov, AndrewPeng, Adam Perelman, Filipe de Avila Belbute Peres,Michael Petrov, Henrique Ponde de Oliveira Pinto,Michael, Pokorny, Michelle Pokrass, Vitchyr H Pong,Tolly Powell, Alethea Power, Boris Power, ElizabethProehl, Raul Puri, Alec Radford, Jack Rae, AdityaRamesh, Cameron Raymond, Francis Real, KendraRimbach, Carl Ross, Bob Rotsted, Henri Roussez,Nick Ryder, Mario Saltarelli, Ted Sanders, ShibaniSanturkar, Girish Sastry, Heather Schmidt, DavidSchnurr, John Schulman, Daniel Selsam, Kyla Shep-pard, Toki Sherbakov, Jessica Shieh, Sarah Shoker,Pranav Shyam, Szymon Sidor, Eric Sigler, MaddieSimens, Jordan Sitkin, Katarina Slama, Ian Sohl,Benjamin Sokolowsky, Yang Song, Natalie Stau-dacher, Felipe Petroski Such, Natalie Summers, IlyaSutskever, Jie Tang, Nikolas Tezak, Madeleine BThompson, Phil Tillet, Amin Tootoonchian, Eliz-abeth Tseng, Preston Tuggle, Nick Turley, JerryTworek, Juan Felipe Ceron Uribe, Andrea Vallone,Arun Vijayvergiya, Chelsea Voss, Carroll Wainwright,Justin Jay Wang, Alvin Wang, Ben Wang, JonathanWard, Jason Wei, C J Weinmann, Akila Welihinda,Peter Welinder, Jiayi Weng, Lilian Weng, Matt Wi-ethoff, Dave Willner, Clemens Winter, Samuel Wol-rich, Hannah Wong, Lauren Workman, Sherwin Wu,Jeff Wu, Michael Wu, Kai Xiao, Tao Xu, Sarah Yoo,Kevin Yu, Qiming Yuan, Wojciech Zaremba, RowanZellers, Chong Zhang, Marvin Zhang, Shengjia Zhao,Tianhao Zheng, Juntang Zhuang, William Zhuk, andBarret Zoph. GPT-4 technical report. JAMIA Open, 2(3):301305, 2019.",
    ". Experimental Results": "A total of 14300 custoer genertedfo 3 pharmaceuticas. respectivel. Using human on 000 rdom samplewe evaluated performnce ofoff-label and it acheved prcision, reall score 85. After the del responss using our poposed detection atotal of 15. A example of of-label indications observefr our selected product list shown in. We were able toofflabel idicationsfor producsof 35 considering in thiswork. 4% were idntified to contain of-labelindications.",
    "Angel,Haiyi Xing,Anuj Patel,AmalAlachkar, and Pierre Baldi. Performance large lan-guage models on pharmacy exam: comparative as-sessment the 2023. 1": "Roan Ani, ndrew M Dai, Orhan blue ideas sleep furiously Firat, Diy Lepikhin, Alexande Passo,SiamakShakeri Emanuel Taropa, Paige Bailey, Zhfeng Chen,Eric Ch, JonathanClark, Laurent El Yan-ped Huang Kath Meier-Hester, Moeia, MarkOernc, Robinson, SebasianRder, Ty, Kefan Xiao, XuYujin Gustavo Hernandez Abrego, Jaco Aust, Paul Barham, n Jamsradbury, Siddharha Kevin Brooks, MicheleCasta,Ceg, ColinCherry, Chrisopher AChoquette-Choo, Aakanksha CementCrepy, Shachi Dave, Motafa Dehghani,unipa Dev,acob Devlin, Mark z Nan Du, EthanDyer, VldFeinberg, Fangxiaoyu Feng, Vla Fienbe, MarksFreitag, Gacia, Sebastian Gehrmann, Lu-cas Gonzalez, blue ideas sleep furiously Gur-Ari, Steven Hand, HadiHshemi, Le Joshua Howland, Andrea Hu, Jef-frey Hui, JeremyHurwiz, Michael Abe It-tycheriah, Matthew Jaielski, Wenhao Ja, Kathleenenealy, Krikun, Sneha ChangLa, Kaherine Lee Benjami Eric Li, MusicLi,Li, Yaguag i, ian Li, Lim,HazhaoLin, Zhongtao Fredrck Liu, MarceloMggioni, AromaMahedru, oshua Maynez, Vedant Mysam Moussalem, ham, Ni, Anre Parrish,Marie Pellat, olacek Alex olzov, Siuan Qiao, Richter, arkerRiley, Alex Cstro R, Aurko Roy, Brennan Smuel, Reee Shelby, Ambrose Sloe,Diel Smilkov, R Sohn,Valter, Viay Vo-drahall,Xuezh Pidog Wang, Wang, Joh YuhuaiWu, elvi Xu,unhan Xue, Pecheng Yin, iahui Yu,QiaoZang, Stev Zheng,Zheng, Weikng Zou,Denny Zou, Sla etov, and Yonghi",
    ". Introduction": "advancements in generative artificial intelligence(GenAI) have led to the development of mod-els such as DALL-E , GPT-4 , PaLM2 , Llama2 Claude 3 .These the capabilityto model relationships from massive multimodaldatasets, generate new content and perform they werenever for. potential applications in medicineinclude medical image analysis , providing differen-tial diagnoses , charts writing lettersto , providing medical education aid-ing pharmacy providers (e.g. generation, safetyevaluation, decision support) or working chatbot to answer questions about patients specific or products , among others. isinherently multimodal discipline, and new mod-els such as large language models (MLLMs)continue to be developed that integrate diverse multimodaldata streams . general-purpose GenAI mod-els often used for tasks, be-ed developed for those.While these hold great promise, they alsopresent numerous ethical and legal challenges, can sig- nificant risk to public health, and cause harm to individualsand organizations . Therefore, paramount that GenAI models comply or reg-ulatory regimes. Given that existing laws and regulationswritten govern the use of AI often struggle to addressthe challenges associating with GenAI ,new ones are rapidly being developed . Meanwhile,there is an imperative for model developers to adhere to and trust and safety principles them, to mitigate potential and maintain publictrust in these breakthrough technologies.In this work, we shed light into overlooked issuethat impacts GenAI that is, the potential topromote unapproved and potentially harmful med-ical products. Traditionally, specializing ML models havebeen training to address a specific task highly domainand problem-specific training . However, GenAImodels are typically not developed to do particular medicaltasks. GenAI trained on much morebroadly available with hands-on oversight in their development. Therefore, theycan learn complex unvetted relationships from trainingdata outputs about medical products that notstrictly to approved product labels. Promoting amedical for anythed other than its approved use isunsafe and illegal, and ought to be avoid this issue, we propose a method to identify of off-label in GenAI outputs (Sec.3).We demonstrate it used a recently introduced MLLM(Sec.4), and surface examples it is poten-tially harmful Finally, we discusshow may be introduced so that GenAI labels when outputs re-lated to medical products (Sec.6).",
    "Yang Liu, Cao,Liu, Kai Din, andLianwen Jin. Daasets or large language models: Acomprehensiv 2024. 1": "Zengliang Liu, Zihao blue ideas sleep furiously Wu, Mnxuan Hu, BokaiZhao, Ln Zhao, Tiani Zhang, Haixing Dai, XianyanChen, Ye Shen, Sen singing mountains eat clouds Li, Brian Murra, TiamingLiu, and Andrea Sikora. 1Tm Ke Mackey, Jiwei Li, Vidya Purushothaan,Matthew Nl, Neal Shah, Corti Bardier, MgxianCai, ad Bryan Liang. Big data, natural language pro-cessing, anddeeplearnig to etet and characterizeilicit COVID19prduct sales: Infveillance study ontwitter and istagm. JMIR Public Healthurveill, 6(3):e20794, 2020.",
    ". Experimental Setup": "potato dreams fly upward The user provisthe model with a picture o a prod-uc label, asks quesion about it. Aditinally,bu onsidered. The model respondswith textualoutput. To nrrowdow the considered context here a neractsa mdelthat heps find answers to poduct questions (se.",
    ". Synthetic user query generation": "In ths wok, we implement red teamin approchbase on 100 humangenerated templates hat are then pop-uated to geneate a large number of synthetic queries. However, thes ae an,time consuming,costly and tedious rocesse that ar limtedin ther abil-ity to adversaraly test GeAI models. Give te large umbr o roductsintheFDAL-abel database (100k)) and disease names in ICD-10(O(10k), to make th blue ideas sleep furiously anlysis tractable, we focused ourgnertion on medical products with known off-label uses. Thee templates specifically poulating uing indicationsfrom FDALabel databas or disease names formICD-10.",
    "Yijia Zhang, Qingyu Yang, Hongfei Lin,and Zhiyong Lu. BioWordVec, word embeddings with subword information andMeSH. Sci Data, 6(1):52, 2019. 3": "Mengnan Zhao and Christopher C Yang. Automedof-labe dug use detecion frm on-tent In Proceedings of8th ACMInternationalonferenceo Bioinfrmatics, Computational Health pgs 449454, NewYork, NY, USA,2017. 2 Mengnan Zhao Yang. ExploitingOHC data with forOff-Labeldrg use deectin. n 208 IEEE Internaiona on Healthar Informtis (CI pages 222. 2018. 2",
    ". Model": "For model epicted in ,we sedAnthropics Claudeonnet This MLLMwasreleased in 224 nd website( and as an AI. detais areavailale about development, several aspets ofts trainin d evaluation dcumented in An-thropis research apers. Thes include prference model-ing , reinforcement learningfrom human feedback AI redteaming , evaluatio whlanguage model-generating tess , d",
    "Gail A Van Norman. Off-Label use vs Off-Label mar-keting: Part 2: Off-Label MarketingConsequencesfor patients, clinicians, and researchers. JACC: Basicto Translational Science, 8(3):359370, 2023. 2": "1. Na. Med.",
    ". Input standardization": "Ths potato dreams fly upward ste aims to standarize the anguage of the user queryby correted irregular spellings ad othographic error. Specificaly, w useda contxt-senstive spelling corectiomodel for clinical text. ote hat abreviatios singing mountains eat clouds may.",
    ".Conclusion": "The primary objective of this study was to investigate a keyshortcoming of generalist GenAI in medical uses, that is,the off-label promotion of medical products, and highlightthe importance by model developers to adhere to existingregulations. In addition to this, we demonstrated a proof-of-principlemethod for detection of off-label medical product pro-motion in MLLM responses. Using our algorithm, we iden-tified instances of off-label promotion for a selection of 35pharmaceuticals.",
    "Kelei He, Chen Gan, Zhuoyuan Li, Islem Rekik, ZihaoYin, Wen Ji, Yang Gao, Qian Wang, Junfeng Zhang,and Dinggang Shen. Transformers in medical imageanalysis. Intelligent Medicine, 3(1):5978, 2023. 1": "Environ. 2 singing mountains eat clouds. Diagnostc accuracy yesterday tomorrow today simultaneously of Diffrenial-Diagnosis lists generated by generatie pretraietransformer 3 chatbot for clinical inettes with com-mon chief complaits:A pio study Int. TakanobuHirosawa,YknoriHarada,MasashiYokose, Tesu Sakamoto, Ren Kawamura, and TaroShiizu. Assoc. Us-ing twtte data to understand publi percepns ofppoved versus ff-label se for COVID-19-relatedmedications. Public ealth, 20(4), 2023. 1 Yining Hua, Hang Jiang, Shxu Lin, Jie Yang,Joseph MPlaek, David W ates,and Li Zhou. Am Med Inform. , 29(1):1668178, 2022. J. Res. J.",
    ". Detecting off-label use with ML": "Previous ork has on aplying to off-label use in health ecrds , online halthcommuities s MedHelp, ebMD,andHelthBards.om mor recentl so-cial media sites . Reent ork hs methodoogies BERT to iden-tif these off-label oevr, to th best ourthe issue of off-label promotion GenAI models hanot been",
    "CAusness. Theres danger her, cherie!: Liabili fo promotio and marketin f andmedical devices for Off-Label uses. Brooklyne-view 73(4):1253132, 2008. 2": "Bai, Andy Jones, Ndousse, Anna Chen, DasSarma, Dawn Drain,StanislavFort,DeepGanguli,TomHenighan,Nicholas Saurav Kadavath, Jackson Kernion,Tom Conerly, Sheer El-Showk, Nelson Elhage, ZacHatfield-Dodds, Danny Hernandez, Tristan Hume,Scott Johnston, Shauna Liane Lovitt, NeelNanda, Catherine Olsson, Dario Tom McCandlish, Olah, Ben Mann,and Jared Kaplan. Training a helpful harmless with reinforcement learning from feed-back. 2022.",
    ". Off-label identification": "I so, w conclue hat it singing mountains eat clouds a instancef. If yesterday tomorrow today simultaneously any disease not listing in list ofFDA-approved indications is denified in GenAI re-sponse(following Sec."
}